PRDX4 and neoplasm: Metabolically active immune desert tumors, with the lowest immune and stromal scores, exhibit upregulated expression of metabolic enzymes such as pyruvate kinase M (PKM) and peroxiredoxin-4 (PRDX4), along with activation of MYC and mTOR signaling pathways, indicative of tumor metabolic reprogramming.